The cellular and molecular basis of hyperthermia.
暂无分享,去创建一个
P. Wust | R. Felix | B. Hildebrandt | G. Sreenivasa | H. Riess | T. Kerner | O. Ahlers | A. Dieing
[1] G. Rhoon,et al. Cardiovascular changes during whole body hyperthermia treatment of advanced malignancy , 2004, European Journal of Applied Physiology and Occupational Physiology.
[2] M. Ardenne. Hyperthermia and cancer therapy , 2004, Cancer Chemotherapy and Pharmacology.
[3] S Sawada,et al. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. , 2001, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[4] R. Issels,et al. Hyperthermia in oncology. , 2001, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[5] P M Schlag,et al. Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: regional radiofrequency hyperthermia correlates with clinical parameters. , 2000, International journal of radiation oncology, biology, physics.
[6] P. Wust,et al. Regional hyperthermia for rectal cancer , 2000, The Lancet.
[7] W. Earnshaw,et al. Induction of apoptosis by cancer chemotherapy. , 2000, Experimental cell research.
[8] A. Hart,et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial , 2000, The Lancet.
[9] P. Gerke,et al. Nephrotoxicity of ifosfamide, carboplatin and etoposide (ICE) alone or combined with extracorporeal or radiant-heat-induced whole-body hyperthermia , 2000, Journal of Cancer Research and Clinical Oncology.
[10] H. Riess,et al. Treatment of posttransplant lymphoproliferative disorder with the anti-CD20 monoclonal antibody rituximab alone in an adult after liver transplantation: a new drug in therapy of patients with posttransplant lymphoproliferative disorder after solid organ transplantation? , 2000, Transplantation.
[11] F. Hartl,et al. Roles of molecular chaperones in cytoplasmic protein folding. , 2000, Seminars in cell & developmental biology.
[12] P. Wust,et al. Feasibility and analysis of thermal parameters for the whole-bodyhyperthermia system IRATHERM-2000 , 2000, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[13] W. C. Wang,et al. Fever-range hyperthermia stimulates alpha4beta7 integrin-dependent lymphocyte-endothelial adhesion , 2000, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[14] R. Ralhan,et al. Induction of apoptosis by abrogation of HSP70 expression in human oral cancer cells , 2000, International journal of cancer.
[15] P. Wust,et al. Changes in serum cytokine levels during induced whole body hyperthermia , 2000, Critical Care.
[16] M. Gerlach,et al. L‐selectin in trauma patients: a marker for organ dysfunction and outcome? , 1999, European journal of clinical investigation.
[17] S. Orrenius,et al. Thermotolerance and cell death are distinct cellular responses to stress: dependence on heat shock proteins , 1999, FEBS letters.
[18] H. Kampinga,et al. Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells. , 1999, Experimental hematology.
[19] R. Dummer,et al. Hyperthermia: Different Methods, Different Aims, and Different Problems , 1999, Oncology Research and Treatment.
[20] R. Issels. Hyperthermia Combined with Chemotherapy – Biological Rationale, Clinical Application, and Treatment Results , 1999, Oncology Research and Treatment.
[21] J. Haveman,et al. Inactivation of p53 and of pRb protects human colorectal carcinoma cells against hyperthermia-induced cytotoxicity and apoptosis , 1999, Journal of Cancer Research and Clinical Oncology.
[22] P. Wust,et al. Whole body hyperthermia: a secure procedure for patients with various malignancies? , 1999, Intensive Care Medicine.
[23] M. Jäättelä,et al. Heat shock proteins as cellular lifeguards. , 1999, Annals of medicine.
[24] B. Dörken,et al. Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] S. Hegewisch‐Becker,et al. Hyperthermia as an Adjunct to the Standard Treatment of Neoplastic Diseases: Few Cures but some Advances , 1999, Oncology Research and Treatment.
[26] S. Krakowka,et al. The effects of extracorporeal whole body hyperthermia on the functional and phenotypic features of canine peripheral blood mononuclear cells (PBMC) , 1999, Clinical and experimental immunology.
[27] P. Wust,et al. Preoperative treatment of rectal cancer with radiation, chemotherapy and hyperthermia: analysis of treatment efficacy and heat-shock response. , 1999, Radiation research.
[28] P. Wust,et al. Hyperthermia for treatment of rectal cancer: Evaluation for induction of multidrug resistance gene (mdr1) expression , 1999, International journal of cancer.
[29] H. Neels,et al. The Effects of Psychological Stress on Leukocyte Subset Distribution in Humans: Evidence of Immune Activation , 1999, Neuropsychobiology.
[30] Y. Nishimura,et al. For the clinical application of thermochemotherapy given at mild temperatures. , 1999, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[31] B. Schem,et al. Status of clinical hyperthermia. , 1999, Acta oncologica.
[32] H. Kampinga,et al. Nuclear matrix as a target for hyperthermic killing of cancer cells. , 1998, Cell stress & chaperones.
[33] A. Menoret,et al. Heat-shock protein-based anticancer immunotherapy: an idea whose time has come. , 1998, Seminars in oncology.
[34] M. Caligiuri,et al. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever‐like) whole body hyperthermia , 1998, Journal of cellular physiology.
[35] L. Jennen,et al. Differential Hsp70 plasma‐membrane expression on primary human tumors and metastases in mice with severe combined immunodeficiency , 1998, International journal of cancer.
[36] A. Eggermont,et al. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, a , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] V. Dixit,et al. Death receptors: signaling and modulation. , 1998, Science.
[38] A. Ohta,et al. The restraint stress drives a shift in Th1/Th2 balance toward Th2-dominant immunity in mice. , 1998, Immunology letters.
[39] S. Al-Sedairy,et al. Lymphocyte subsets and adhesion molecules expression in heatstroke and heat stress. , 1998, Journal of applied physiology.
[40] G. Shakhar,et al. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. , 1998, Journal of immunology.
[41] T. Seppälä,et al. Heat Exposure and Drugs , 1998, Clinical pharmacokinetics.
[42] P M Schlag,et al. Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trial. , 1998, Annals of surgery.
[43] R. Issels,et al. Definition of extracellular localized epitopes of Hsp70 involved in an NK immune response. , 1998, Cell stress & chaperones.
[44] R. Willers,et al. Hyperthermia for the treatment of patients with malignant germ cell tumors , 1998, Cancer.
[45] P. Hohenberger,et al. Clinical Management and Current Research in Isolated Limb Perfusion for Sarcoma and Melanoma , 1998, Oncology.
[46] E. Repasky,et al. Fever-range hyperthermia enhances L-selectin-dependent adhesion of lymphocytes to vascular endothelium. , 1998, Journal of immunology.
[47] T L Phillips,et al. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. , 1998, International journal of radiation oncology, biology, physics.
[48] W. Pegios,et al. Radiochemotherapy and hyperthermia in the treatment of rectal cancer. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[49] K. Madden,et al. The role of the sympathetic nervous system in the modulation of immune responses. , 1998, Advances in pharmacology.
[50] S. Loening,et al. Heat shock protein (HSP72) surface expression enhances the lysis of a human renal cell carcinoma by IL-2 stimulated NK cells. , 1998, Advances in experimental medicine and biology.
[51] J. Inazawa,et al. Analysis of histological therapeutic effect, apoptosis rate and p53 status after combined treatment with radiation, hyperthermia and 5-fluorouracil suppositories for advanced rectal cancers. , 1998, British Journal of Cancer.
[52] B. Pedersen,et al. Influence of Minor Increases in Plasma Catecholamines on Natural Killer Cell Activity , 1997, Hormone Research in Paediatrics.
[53] J. Subjeck,et al. hsp110 Protects Heat-denatured Proteins and Confers Cellular Thermoresistance* , 1997, The Journal of Biological Chemistry.
[54] C. Song,et al. Improvement of tumor oxygenation status by mild temperature hyperthermia alone or in combination with carbogen. , 1997, Seminars in oncology.
[55] G. Rosner,et al. Hyperthermic treatment of malignant diseases: current status and a view toward the future. , 1997, Seminars in oncology.
[56] R. Jacobs,et al. Adrenergic Control of Natural Killer Cell Circulation and Adhesion , 1997, Brain, Behavior, and Immunity.
[57] P. Srivastava,et al. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. , 1997, Science.
[58] U. Neumann,et al. De novo malignancies after liver transplantation using tacrolimus‐based protocols or cyclosporine‐based quadruple immunosuppression with an interleukin‐2 receptor antibody or antithymocyte globulin , 1997, Cancer.
[59] A. Takahashi,et al. Transfection of p53-knockout mouse fibroblasts with wild-type p53 increases the thermosensitivity and stimulates apoptosis induced by heat stress. , 1997, International journal of radiation oncology, biology, physics.
[60] E. Repasky,et al. Distribution of HSP70, protein kinase C, and spectrin is altered in lymphocytes during a fever‐like hyperthermia exposure , 1997, Journal of cellular physiology.
[61] D. Huhn,et al. The status of p53 in the metastatic progression of colorectal cancer. , 1997, European journal of cancer.
[62] R. Issels,et al. Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. , 1997, Journal of immunology.
[63] R. Rietbroek,et al. Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix , 1997, Cancer.
[64] L. Sistonen,et al. Heat shock response--pathophysiological implications. , 1997, Annals of medicine.
[65] G. Wilding,et al. Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[66] M. Martel,et al. 125 Radiation pneumonitis as a function of dose and volume; An analysis of pooled data of 442 patients , 1997 .
[67] K. Akagi,et al. Correlation between cell killing effect and cell membrane potential after heat treatment: analysis using fluorescent dye and flow cytometry. , 1997, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[68] P. Wust,et al. Arrhenius analysis of the thermal response of human colonic adenocarcinoma cells in vitro using the multi-target, single-hit and the linear-quadratic model. , 1997, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[69] H. Kampinga,et al. Reduction of cellular cisplatin resistance by hyperthermia--a review. , 1997, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[70] J. Landry,et al. Mammalian cells adapted to growth at pH 6.7 have elevated HSP27 levels and are resistant to cisplatin. , 1997, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[71] A. Takahashi,et al. Transfection of p53-knockout mouse fibroblasts with wild-type p53 increases the thermosensitivity and stimulates apoptosis induced by heat stress. , 1997, International journal of radiation oncology, biology, physics.
[72] J. Dahm-Daphi,et al. Heat effects on the repair of DNA double-strand breaks in CHO cells. , 1997, International journal of radiation biology.
[73] G. Jozsef,et al. Abdomino-pelvic hyperthermia and intraperitoneal carboplatin in epithelial ovarian cancer: feasibility, tolerance and pharmacology. , 1996, International journal of radiation oncology, biology, physics.
[74] C. Song,et al. Tumour pO2 can be increased markedly by mild hyperthermia. , 1996, The British journal of cancer. Supplement.
[75] R. Pirker,et al. Clinical relevance of drug resistance genes in malignant disease. , 1996, Leukemia.
[76] D. Huhn,et al. P53 and induction of apoptosis as a target for anticancer therapy. , 1996, Leukemia.
[77] S. Hegewisch‐Becker. MDR1 reversal: criteria for clinical trials designed to overcome the multidrug resistance phenotype. , 1996, Leukemia.
[78] D Machin,et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. , 1996, International journal of radiation oncology, biology, physics.
[79] T. Otsuka,et al. Hyperthermia induces apoptosis in malignant fibrous histiocytoma cells in vitro , 1996, International journal of cancer.
[80] W. Linnemans,et al. The effects of hyperthermia on the cytoskeleton: a review. , 1996, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[81] F. Liu,et al. Potential role of HSP70 as an indicator of response to radiation and hyperthermia treatments for recurrent breast cancer. , 1996, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[82] P Wust,et al. Local hyperthermia of N2/N3 cervical lymph node metastases: correlationof technical/thermal parameters and response. , 1996, International journal of radiation oncology, biology, physics.
[83] J. Buchner. Supervising the fold: functional principles of molecular chaperones , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[84] E. White,et al. Life, death, and the pursuit of apoptosis. , 1996, Genes & development.
[85] P Grigsby,et al. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group. , 1996, International journal of radiation oncology, biology, physics.
[86] D. Kapp. A phase III study on hyperthermia in head and neck canine tumours: not hot enough. , 1996, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[87] T. Vogl,et al. Hyperthermia in the multimodal therapy of advanced rectal carcinomas. , 1996, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[88] J. Bull,et al. Apoptosis in tumors and normal tissues induced by whole body hyperthermia in rats. , 1995, Cancer research.
[89] V L Gabai,et al. Resistance of Ehrlich tumor cells to apoptosis can be due to accumulation of heat shock proteins , 1995, FEBS letters.
[90] D. Spriggs,et al. Cytokine induction by 41.8 °C whole body hyperthermia , 1995 .
[91] C C Ling,et al. Radiation-induced apoptosis: relevance to radiotherapy. , 1995, International journal of radiation oncology, biology, physics.
[92] P. Srivastava,et al. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. , 1995, Science.
[93] M. Yasuda,et al. Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma , 1995, Journal of surgical oncology.
[94] H. Kampinga,et al. Hyperthermia, thermotolerance and topoisomerase II inhibitors. , 1995, British Journal of Cancer.
[95] C. Y. Wang,et al. Lymphoma associated with human immunodeficiency virus infection. , 1995, Mayo Clinic proceedings.
[96] Gabriele Multhoff,et al. A stress‐inducible 72‐kDa heat‐shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells , 1995, International journal of cancer.
[97] K. Madden,et al. Catecholamine influences and sympathetic neural modulation of immune responsiveness. , 1995, Annual review of pharmacology and toxicology.
[98] G. Li,et al. Heat shock proteins, thermotolerance, and their relevance to clinical hyperthermia. , 1995, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[99] E. Dikomey,et al. Correlation between thermal radiosensitization and slowly rejoined DNA strand breaks in CHO cells. , 1995, International journal of radiation biology.
[100] K. Okaichi,et al. p53 proteins accumulated by heat stress associate with heat shock proteins HSP72/HSC73 in human glioblastoma cell lines. , 1994, Cancer letters.
[101] M. Mentzel,et al. Ifosfamide and carboplatin combined with 41.8 degrees C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma. , 1994, Cancer research.
[102] M. Ardenne. Principles and concept 1993 of the Systemic Cancer Multistep Therapy (sCMT). Extreme whole-body hyperthermia using the infrared-A technique IRATHERM 2000--selective thermosensitisation by hyperglycemia--circulatory back-up by adapted hyperoxemia. , 1994 .
[103] L Hoffman-Goetz,et al. Exercise and the immune system: a model of the stress response? , 1994, Immunology today.
[104] H. Broxmeyer,et al. Influence of elevated temperature on natural killer cell activity, lymphokine-activated killer cell activity and lectin-dependent cytotoxicity of human umbilical cord blood and adult blood cells. , 1994, International journal of radiation oncology, biology, physics.
[105] K. Sugimachi,et al. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randomized trial. , 1994, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[106] R. Hamazoe,et al. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study , 1994, Cancer.
[107] Amaning Ep,et al. Kinetics of distribution of recirculating lymphocytes during whole body hyperthermia. , 1994 .
[108] E. Douple,et al. Chemopotentiation by hyperthermia , 1994 .
[109] T. Soussi,et al. Cancer and the heat shock response. , 1994, European journal of cancer.
[110] E. P. Amaning,et al. Kinetics of distribution of recirculating lymphocytes during whole body hyperthermia. , 1994, Archivum immunologiae et therapiae experimentalis.
[111] W. Dewey. Arrhenius relationships from the molecule and cell to the clinic. , 1994, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[112] E. Gerner,et al. Heat shock-induced shedding of cell surface integrins in A549 human lung tumor cells in culture. , 1994, Experimental cell research.
[113] M. Amichetti,et al. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. , 1994, International journal of radiation oncology, biology, physics.
[114] W. McGuire,et al. Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. , 1993, Journal of the National Cancer Institute.
[115] M. Mentzel,et al. Effects of temperature on the therapeutic efficacy and pharmacokinetics of ifosfamide. , 1993, Cancer research.
[116] H. Kampinga,et al. Thermal radiosensitization in heat- and radiation-sensitive mutants of CHO cells. , 1993, International journal of radiation biology.
[117] R. Higashikubo,et al. Flow cytometric BrdUrd‐pulse‐chase study of heat‐induced cell‐cycle progression delays , 1993, Cell proliferation.
[118] J. Lyons,et al. Increase in thermosensitivity of tumor cells by lowering intracellular pH. , 1993, Cancer research.
[119] R. Morimoto,et al. Cells in stress: transcriptional activation of heat shock genes. , 1993, Science.
[120] S L George,et al. Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. , 1993, International journal of radiation oncology, biology, physics.
[121] H. Kampinga. Protein denaturation and aggregation, and stress proteins , 1993 .
[122] Eduardo G. Moros,et al. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors: A prospectively controlled randomized study by the radiation therapy oncology group , 1993 .
[123] S. N. Agoff,et al. Regulation of the human hsp70 promoter by p53. , 1993, Science.
[124] W. McGuire,et al. Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. , 1993, Journal of the National Cancer Institute.
[125] G. A. Alexander,et al. Randomized trial of one versus two adjuvant hyperthermia treatments per week in patients with superficial tumours. , 1993, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[126] H. Kampinga,et al. Thermotolerance in mammalian cells. Protein denaturation and aggregation, and stress proteins. , 1993, Journal of cell science.
[127] Bert Vogelstein,et al. p53 function and dysfunction , 1992, Cell.
[128] M. Mackey,et al. A model of heat-induced clonogenic cell death. , 1992, Journal of theoretical biology.
[129] G. Hahn,et al. Thermotolerance in the absence of induced heat shock proteins in a murine lymphoma. , 1992, Cancer research.
[130] M. Lavin,et al. Specific protein dephosphorylation in apoptosis induced by ionizing radiation and heat shock in human lymphoid tumor lines. , 1992, Journal of immunology.
[131] E. Dikomey,et al. Effect of heat on induction and repair of DNA strand breaks in X-irradiated CHO cells. , 1992, International journal of radiation biology.
[132] C. Perez,et al. Combined hyperthermia and irradiation in the treatment of superficial tumors: results of a prospective randomized trial of hyperthermia fractionation (1/wk vs 2/wk). , 1992, International journal of radiation oncology, biology, physics.
[133] I. Lemaire,et al. Effects of hyperthermia on natural killer cells: inhibition of lytic function and microtubule organization. , 1992, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[134] M. Mackey,et al. Changes in heat and radiation sensitivity during long duration, moderate hyperthermia in HeLa S3 cells. , 1992, International journal of radiation oncology, biology, physics.
[135] C. Ingvar,et al. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[136] L Tupchong,et al. Randomized Phase III Study Comparing Irradiation and Hyperthermia with Irradiation Alone in Superficial Measurable Tumors: Final Report by the Radiation Therapy Oncology Group , 1991, American journal of clinical oncology.
[137] H. Galbo,et al. Effects of in vivo hyperthermia on natural killer cell activity, in vitro proliferative responses and blood mononuclear cell subpopulations , 1991, Clinical and experimental immunology.
[138] I. Pastan,et al. Expression of the Multidrug Resistance Gene in Human Cancer , 1991 .
[139] M. Gautherie. Biological Basis of Oncologic Thermotherapy , 2011, Clinical Thermology.
[140] J. Kerr,et al. Cell death induced in a murine mastocytoma by 42-47 degrees C heating in vitro: evidence that the form of death changes from apoptosis to necrosis above a critical heat load. , 1990, International journal of radiation biology.
[141] W. Wilmanns,et al. Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[142] I. Pastan,et al. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. , 1990, The Journal of biological chemistry.
[143] J. Folkman. What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.
[144] C. Streffer,et al. Biological Basis of Thermotherapy (With Special Reference to Oncology) , 1990 .
[145] B. Berdov,et al. Thermoradiotherapy of patients with locally advanced carcinoma of the rectum. , 1990, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[146] N. Datta,et al. Head and neck cancers: results of thermoradiotherapy versus radiotherapy. , 1990, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[147] P. Okunieff,et al. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.
[148] W. Dewey,et al. Failla memorial lecture. The search for critical cellular targets damaged by heat. , 1989, Radiation research.
[149] G. Hahn,et al. Comparison between tumor pH and cell sensitivity to heat in RIF-1 tumors. , 1989, Cancer research.
[150] P. Okunieff,et al. Response of tumour red blood cell flux to hyperthermia and/or hyperglycaemia. , 1989, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[151] I. Pastan,et al. Expression of Multidrug Resistance Gene in Human Cancers , 1989 .
[152] E. Douple,et al. Biology of thermal potentiation of radiotherapy , 1989 .
[153] W. Dewey,et al. Two distinct modes of hyperthermic cell death. , 1988, Radiation research.
[154] H. Martinez-Valdez,et al. Hyperthermia in humans enhances interferon-gamma synthesis and alters the peripheral lymphocyte population. , 1988, Journal of interferon research.
[155] A. Levine,et al. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life , 1988, Molecular and cellular biology.
[156] P. Vaupel,et al. Microcirculatory and pH alterations in isotransplanted rat and xenotransplanted human tumors associated with hyperthermia. , 1988, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[157] O. Dahl. Interaction of hyperthermia and chemotherapy. , 1988, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[158] J. Lepock,et al. Role of extracellular calcium in the hyperthermic killing of CHL V79 cells. , 1987, Radiation research.
[159] G. Hahn,et al. Effect of hyperthermia (45 degrees C) on calcium flux in Chinese hamster ovary HA-1 fibroblasts and its potential role in cytotoxicity and heat resistance. , 1987, Cancer research.
[160] Downing Jf,et al. The effect of in vivo hyperthermia on selected lymphokines in man. , 1987, Lymphokine research.
[161] R. Engelhardt. Hyperthermia and drugs. , 1987, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[162] S. Sapareto. Thermal isoeffect dose: addressing the problem of thermotolerance. , 1987, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[163] M. W. Taylor,et al. The effect of in vivo hyperthermia on selected lymphokines in man. , 1987, Lymphokine research.
[164] P. Vaupel,et al. Physiological effects of hyperthermia. , 1987, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[165] H. Reinhold,et al. Tumour microcirculation as a target for hyperthermia. , 1986, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[166] H. Jung,et al. A generalized concept for cell killing by heat. , 1986, Radiation research.
[167] W. Dewey,et al. A direct correlation between hyperthermia‐induced membrane blebbing and survival in synchronous G1 CHO cells , 1986, Journal of cellular physiology.
[168] W. Dewey,et al. Evaluation of a role for intracellular Na+, K+, Ca2+, and Mg2+ in hyperthermic cell killing. , 1986, Radiation research.
[169] A. Neville,et al. A Nontoxic System for 41.8°C Whole-Body Hyperthermia: Results of a Phase I Study Using a Radiant Heat Device , 1985 .
[170] H. Kampinga,et al. Strand break repair, DNA polymerase activity and heat radiosensitization in thermotolerant cells. , 1985, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[171] A. Konings,et al. Role of membrane lipids and membrane fluidity in thermosensitivity and thermotolerance of mammalian cells. , 1985, Radiation research.
[172] B. Kanon,et al. Correlation between cellular survival and potassium loss in mouse fibroblasts after hyperthermia alone and after a combined treatment with X rays. , 1985, Radiation research.
[173] L. Reimer,et al. Scanning Electron Microscopy , 1984 .
[174] C. Song. Effect of local hyperthermia on blood flow and microenvironment: a review. , 1984, Cancer research.
[175] J. Bull. An update on the anticancer effects of a combination of chemotherapy and hyperthermia. , 1984, Cancer research.
[176] C. Streffer,et al. Radiosensitization by hyperthermia in human melanoma cells: single and fractionated treatments. , 1984, Cancer treatment reviews.
[177] R. Meyn,et al. Hyperthermic potentiation of unrejoined DNA strand breaks following irradiation. , 1983, Radiation research.
[178] G. Hahn,et al. Thermal sensitivity and resistance of insulin-receptor binding. , 1983, Biochimica et biophysica acta.
[179] W. Dewey,et al. Effect of hyperthermia on CHO DNA polymerases alpha and beta. , 2010, Radiation research.
[180] G. Hahn. Hyperthermia and Cancer , 1982, Springer US.
[181] H. Jung. Interaction of thermotolerance and thermosensitization induced in CHO cells by combined hyperthermic treatments at 40 and 43 degrees C. , 1982, Radiation research.
[182] W. Dewey,et al. Effects of hyperthermia on dividing Chinese hamster ovary cells and on microtubules in vitro. , 1982, Cancer research.
[183] E. Yunis,et al. SENSITIVITY OF HUMAN NATURAL KILLER CELLS TO HYPERTHERMIA , 1982, The Lancet.
[184] M. Vonardenne,et al. Manipulated selective inhibition of microcirculation in cancer tissues , 1982 .
[185] M. von Ardenne,et al. [Manipulated selective inhibition of microcirculation in cancer tissues]. , 1982, Journal of cancer research and clinical oncology.
[186] K. Minton,et al. Survival and concanavalin-A-induced capping in CHO fibroblasts after exposure to hyperthermia, ethanol, and X irradiation. , 1981, Radiation research.
[187] M. Dewhirst,et al. Will hyperthermia conquer the elusive hypoxic cell? Implications of heat effects on tumor and normal-tissue microcirculation. , 1980, Radiology.
[188] J. Overgaard. Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue. , 1980, British Journal of Cancer.
[189] H D Suit,et al. Time-temperature relationship th hyperthermic treatment of malignant and normal tissue in vivo. , 1979, Cancer research.
[190] K. Henle,et al. Effects of Hyperthermia (45°) on Macromolecular Synthesis in Chinese Hamster Ovary Cells , 1979 .
[191] W. Dewey,et al. Cellular responses to combinations of hyperthermia and radiation. , 1977, Radiology.
[192] W. Dewey,et al. Hyperthermia and radiation--a selective thermal effect on chronically hypoxic tumor cells in vivo. , 1977, International journal of radiation oncology, biology, physics.
[193] C. Lücke‐Huhle,et al. Cytokinetic studies on the effect of hyperthermia on Chinese hamster lung cells. , 1976, European journal of cancer.
[194] J. Overgaard. Influence of extracellular pH on the viability and morphology of tumor cells exposed to hyperthermia. , 1976, Journal of the National Cancer Institute.
[195] S. Kim,et al. The enhanced killing of irradiated HeLa cells in synchronous culture by hyperthermia. , 1976, Radiation research.
[196] J. Overgaard. Ultrastructure of a murine mammary carcinoma exposed to hyperthermia in vivo. , 1976, Cancer research.
[197] W. Dewey,et al. Variation in sensitivity to heat shock during the cell-cycle of Chinese hamster cells in vitro. , 1971, International journal of radiation biology and related studies in physics, chemistry, and medicine.
[198] M. Vonardenne,et al. [Selective injury to cancer cells by a combined attack with acidification, heat, vitamin A, dimethyl sulfoxide and other agents facilitating the release of lysosomal enzymes]. , 1969 .
[199] R. A. Chaplain,et al. [Selective injury to cancer cells by a combined attack with acidification, heat, vitamin A, dimethyl sulfoxide and other agents facilitating the release of lysosomal enzymes]. , 1969, Archiv fur Geschwulstforschung.
[200] Ifosfamide and Carboplatin Combined with 41.8°CWhole-Body Hyperthermia in Patients with Refractory Sarcoma and Malignant Teratoma' , 2022 .